The Consolidation of Neonatal Respiratory Care

Crius V7 Ventilator – Advanced HFOV Ventilation with Integrated HFNC, NIV & IV Support

Neonatal intensive care has long required a tangle of separate ventilators, oxygen delivery systems, and monitoring tools. The Crius V7 ventilator collapses this setup into a single pneumatic-electronic platform, integrating high-flow nasal cannula (HFNC), non-invasive ventilation (NIV), and invasive ventilation (IV) alongside high-frequency oscillatory ventilation (HFOV).

This matters most in the NICU, where fragile premature lungs demand precise volume and pressure control. HFOV, a mode that delivers very small tidal volumes at high rates, is particularly valuable for avoiding ventilator-induced lung injury in neonates. By embedding it within a system that also handles routine support and weaning, the Crius V7 reduces patient transfers between devices and the clinical errors that come with them.

From a workflow perspective, the consolidation is significant. A single ventilator that covers manual ventilation, constant frequency ventilation, and multiple oxygen therapy modes means fewer machines per bed, simpler training regimens, and a leaner spare-parts pipeline. For hospitals in emerging markets—where China’s medical device sector increasingly competes—these factors lower the total cost of ownership.

The Crius V7 is not a breakthrough in ventilation science. It is an exercise in integration: compressing a decade of respiratory therapy capability into a box that fits within modern ICU logistic constraints. That, increasingly, is where Chinese manufacturers add real value—not in inventing new physiology, but in rationalizing the hardware around it.

Why it matters:
For NICU and PICU operators, the Crius V7 reduces equipment proliferation without sacrificing therapeutic range. For procurement teams, it signals a move toward multi-function capital equipment that compresses both upfront cost and maintenance overhead.

View Product →